The present invention relates to an improved process for the preparation of Trandolapril and intermediate compounds useful in the preparation of Trandolapril.
The preferred drugs in the compositions and methods are verapamil, trandolapril, and hydrochlorothiazide.
The present invention provides an improved process for preparation of highly pure trandolapril.
This product contains 2 medications: trandolapril and verapamil.
They are used as intermediates in the synthesis of ACE inhibitors, especially of enalapril and trandolapril.
Health Canada has issued new restrictions concerning the use of trandolapril.
The present invention relates to two novel crystalline polymorphs of trandolapril, processes for their preparation and the pharmaceutical compositions containing them.
The analysis included 6,400 of the 22,576 participants in the International Verapamil SR-Trandolapril Study (INVEST).
Example of 'prils' include lisinopril, cilazapril, enalapril, benazepril, ramipril, delapril, enalaprilat, imidapril, spirapril, trandolapril and others.
The ACE inhibitor is selected from the group consisting of quinapril, enalapril, spirapril, ramipril, perindopril, indolapril, lisinopril, alacepril, trandolapril, benazapril, libenzapril, delapril, cilazapril and combinations thereof.
A recent study — the International Verapamil-Trandolapril Study (INVEST) — has stirred things up.
Trandolapril can cause serious (possibly fatal) harm to an unborn baby if used during pregnancy.
Fluid and electrolyte balance: Increases in blood levels of potassium may occur as a result of taking perindopril.
In the case of mild to moderate essential hypertension, Prpms-TRANDOLAPRIL can be used alone or in association with thiazide diuretics.
In the case of mild to moderate essential hypertension, Prpms-TRANDOLAPRIL can be used alone or in association with thiazide diuretics.
Pharmascience Inc. launches (Pr)pms-TRANDOLAPRIL, first generic bioequivalent to (Pr)MAVIK® available on the market, for the treatment of mild to moderate essential hypertension Français
A process for preparing trandolapril, (2S,3aR,7aS)-1-[(S)-N-[(S)-1-Carboxy-3-phenylpropyl]alanyl]hexahydro-2-indolinecarboxylic acid, 1-ethyl ester, and intermediates that are useful in the process.
Pharmascience Inc. launches (Pr)pms-TRANDOLAPRIL, first generic bioequivalent to (Pr)MAVIK® available on the market, for the treatment of mild to moderate essential hypertension Français
Pharmascience Inc. launches (Pr)pms-TRANDOLAPRIL, first generic bioequivalent to (Pr)MAVIK® available on the market, for the treatment of mild to moderate essential hypertension
Pharmascience Inc. launches (Pr)pms-TRANDOLAPRIL, first generic bioequivalent to (Pr)MAVIK® available on the market, for the treatment of mild to moderate essential hypertension Français
Requêtes fréquentes français :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Requêtes fréquentes anglais :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Traduction Translation Traducción Übersetzung Tradução Traduzione Traducere Vertaling Tłumaczenie Mετάφραση Oversættelse Översättning Käännös Aistriúchán Traduzzjoni Prevajanje Vertimas Tõlge Preklad Fordítás Tulkojumi Превод Překlad Prijevod 翻訳 번역 翻译 Перевод